Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Pfizer : Israel begins administering Pfizer booster shot to over 60s 

07/30/2021 | 06:53am EDT

Jerusalem, Jul 30 (EFE).- Israel on Friday started administering a Pfizer/BioNTech Covid-19 booster shot to over 60s in efforts to curb the spread of the Delta variant in the country.

President Isaac Herzog was one of the first to receive a third dose of the vaccine, which has already been administered to immunocompromised people in recent weeks and will be given to people over 60 who received the second dose of the jab at least five months ago.

"The only way we can defeat Covid is together. Together means sharing information. Together means sharing methods, technologies, knowledge and practical actions. Israel is open to sharing all the information we can get from this courageous decision. We will win, but together," Israel's Prime Minister Naftali Bennett said during an event for Herzog's inoculation.

The move to offer a third shot to the over 60 population comes after growing concern over the increase of coronavirus cases in Israel, which have reached up to 2,000 cases a day.

Israel was a world leader in vaccination rates and relaxation of restrictions, but after a slow but sudden increase in infections, reintroduced some restrictions at the end of June.

Since Friday, the health passport to enter restaurants and bars was reinforced in the country and a travel ban was extended to 14 countries, including Spain, Argentina, Mexico and Brazil. EFE

© 2021 EFE News Services (U.S.) Inc., source EFE Ingles

All news about PFIZER, INC.
09/17PFIZER : FDA Advisory Committee Votes Unanimously in Favor Of COMIRNATY® Booster..
BU
09/17PFIZER : Astellas' and Pfizer's XTANDI® (enzalutamide) Reduced Risk of Death by ..
PU
09/17PFIZER : SEC charges Florida man for insider trading of Mylan stock
AQ
09/17Wall Street ends rollercoaster week sharply lower
RE
09/17VIATRIS : Former Mylan executive pleads guilty to insider trading
RE
09/17ADRs End Lower, BioNTech Unilever Among Companies Actively Trading
DJ
09/17Healthcare Shares Finish Up Slightly, Beating Broader Market -- Healthcare Ro..
DJ
09/17PFIZER : FDA Panel Votes Down Pfizer COVID-19 Booster Shots for General Public, ..
MT
09/17Wall Street closes rollercoaster week sharply lower
RE
09/17The case for, and against, COVID-19 vaccine boosters
RE
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2021 80 761 M - -
Net income 2021 18 438 M - -
Net Debt 2021 28 980 M - -
P/E ratio 2021 13,0x
Yield 2021 3,59%
Capitalization 246 B 246 B -
EV / Sales 2021 3,41x
EV / Sales 2022 4,03x
Nbr of Employees 78 500
Free-Float 59,3%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | PFE | US7170811035 | MarketScreener
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 20
Last Close Price 43,89 $
Average target price 45,02 $
Spread / Average Target 2,58%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.20.81%246 078
JOHNSON & JOHNSON4.68%434 939
ROCHE HOLDING AG11.70%327 062
NOVO NORDISK A/S51.34%233 887
ELI LILLY AND COMPANY36.28%209 456
ABBVIE INC.0.54%190 996